GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 23 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|